[HTML][HTML] COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
Background Patients with cancer are purported to have poor COVID-19 outcomes. However,
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
LYW Lee, JB Cazier, T Starkey, SEW Briggs… - Lancet …, 2020 - eprints.gla.ac.uk
Background: Patients with cancer are purported to have poor COVID-19 outcomes.
However, cancer is a heterogeneous group of diseases, encompassing a spectrum of …
However, cancer is a heterogeneous group of diseases, encompassing a spectrum of …
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
LYW Lee, JB Cazier, T Starkey, SEW Briggs… - The Lancet …, 2020 - wrap.warwick.ac.uk
Background Patients with cancer are purported to have poor COVID-19 outcomes. However,
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
[PDF][PDF] COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
ADM Briggs, G Middleton, R Kerr, PS Hall… - The Lancet …, 2020 - research.ed.ac.uk
Patients with a diagnosis of cancer are purported to have poor outcomes from COVID-19.
However, cancer is a 51 heterogeneous group of diseases encompassing a spectrum of …
However, cancer is a 51 heterogeneous group of diseases encompassing a spectrum of …
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
LYW Lee, JB Cazier, T Starkey… - The Lancet …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Patients with cancer are purported to have poor COVID-19 outcomes. However,
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study.
LYW Lee, JB Cazier, T Starkey, SEW Briggs… - Lancet …, 2020 - ora.ox.ac.uk
Background Patients with cancer are purported to have poor COVID-19 outcomes. However,
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
LYW Lee, JB Cazier, T Starkey, SEW Briggs… - The Lancet …, 2020 - Elsevier
Background Patients with cancer are purported to have poor COVID-19 outcomes. However,
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
R Lee - Lancet Oncology, 2020 - research.manchester.ac.uk
Background Patients with cancer are purported to have poor COVID-19 outcomes. However,
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
LYW Lee, JB Cazier, T Starkey… - The Lancet …, 2020 - eprints.whiterose.ac.uk
Background Patients with cancer are purported to have poor COVID-19 outcomes. However,
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study.
LYW Lee, JB Cazier, T Starkey, SEW Briggs, R Arnold… - 2020 - cabidigitallibrary.org
Background: Patients with cancer are purported to have poor COVID-19 outcomes.
However, cancer is a heterogeneous group of diseases, encompassing a spectrum of …
However, cancer is a heterogeneous group of diseases, encompassing a spectrum of …